Identification and subsequent removal of an interference by FAIMS in the bioanalysis of dianicline in animal plasma

Bioanalysis

Volumn 3, Issue 18, 2011, Pages 2119-2127

  Blackburn, Michael A ^a   Kapron, James ^b   Mackie, Jennifer ^c   Firth, John ^a   Harrison, Mark ^b   McDougall, Stuart ^a  

^a Sanofi Aventis Isotope Chemistry and Metabolite Synthesis Northumberland   (United Kingdom)

^b Thermo Fisher Scientific   (United States)

^c R Biopharm Rhone RBR Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIANICLINE; KETAMINE;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; DRUG STRUCTURE; FIELD ASYMMETRIC WAVEFORM ION MOBILITY SPECTROMETRY; GOOD LABORATORY PRACTICE; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MACACA; MASS SPECTROMETRY; NONHUMAN; SENSITIVITY AND SPECIFICITY; SPECTROMETRY; VALIDITY;

ANIMALS; AZEPINES; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; KETAMINE; MACACA; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 80053266752     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.194     Document Type: Article

References (18)

1. Johnson T, Joyner M, DePourcq F et al. Using research metrics to improve timelines: proceedings from the 2nd Annual CTSA Clinical Research Management Workshop. Clin. Transl. Sci. 3, 305-308 (2010).
2. Xia YQ, Wu ST, Jemal M. LC-FAIMS-MS/ MS for quantification of a peptide in plasma and evaluation of FAIMS global selectivity from plasma components. Anal. Chem. 80(18), 7137-7143 (2008).
3. Xia YQ, Jemal M. High-field asymmetric waveform ion mobility spectrometry for determining the location of in-source collision-induced dissociation in electrospray ionization mass spectrometry. Anal. Chem. 81(18), 7839-7843 (2009).
4. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays. Workshop/conference Report. AAPS J. 9(1), E30-E42 (2007). (Pubitemid 46296546)
5. US Department of Health and Human Service, US FDA, Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation. MD, USA (2001).
6. Guddat S, Thevis M, Kapron J, Thomas A, Schaenzer W. Application of FAIMS to anabolic androgenic steroids in sport drug testing. Drug Test. Analysis 1(11-12), 545-553 (2009).
7. Kapron JT, Jemal M, Duncan G, Kolakowski B, Purves R. Removal of metabolite interference during liquid chromatography-tandem mass spectrometry using high-field asymmetric waveform ion mobility spectrometry. Rapid Commun. Mass Spectrom. 19, 1979-1983 (2005). (Pubitemid 41026420)
8. Saba J, Bonneil E, Pomiès C, Eng K, Thibault P. Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/orbitrap mass spectrometer. J. Proteome Res. 8, 3355-3366 (2009).
9. Klaassen T, Szwandt S, Kapron JT, Roemer A. Validated quantitation method for a peptide in rat serum using liquid chromatography/high-field asymmetric waveform ion mobility spectrometry. Rapid Commun. Mass Spectrom. 23, 2301-2306 (2009).
10. Kapron J, Wu J, Mauriala T, Clark P, Purves RW, Bateman KP. Simultaneous analysis of prostanoids using liquid chromatography/high-field asymmetric waveform ion mobility spectrometry/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20(10), 1504-1510 (2006).
11. Kelavkar U, Hutzley J, McNally J, Kapron J. FAIMS removes chemical background and interference from the analysis of linoleic acid in cancer cell extracts. Curr. Trends Mass Spectrom. 7 (2007).
12. Li J, Purves RW, Richards JC. Coupling capillary electrophoresis and high-field asymmetric waveform ion mobility spectrometry mass spectrometry for the analysis of complex lipopolysaccharides. Anal. Chem. 76(16), 4676-4683 (2004). (Pubitemid 39079462)
13. Hatsis P, Brockman AH, Wu J-T. Evaluation of high-field asymmetric waveform ion mobility spectrometry coupled to nanoelectrospray ionization for bioanalysis in drug discovery. Rapid Commun. Mass Spectrom. 21, 2295-2300 (2007). (Pubitemid 47121161)
14. Hatsis P, Valaskovic G, Wu J-T. Online nanoelectrospray/high-field asymmetric waveform ion mobility spectrometry as a potential tool for discovery pharmaceutical bioanalysis. Rapid Commun. Mass Spectrom. 23, 3736-3742 (2009).
15. Aksenov AA, Kapron JT. Behaviour of tetraalkylammonium ions in high-field asymmetric waveform ion mobility spectrometry. Rapid Commun. Mass Spectrom. 24, 1392-1396 (2010).
16. Hatsis P, Kapron J. A review on the application of high-field asymmetric waveform ion mobility spectrometry (FAIMS) in drug discovery. Rapid Commun. Mass Spectrom. 22, 735-738 (2008). (Pubitemid 351373957)
17. Champarnaud E, Laures AM-F, Borman PJ et al. Trace level impurity method development with high-field asymmetric waveform ion mobility spectrometry: systematic study of factors affecting the performance. Rapid Comm. Mass Spectrom. 23, 181-193 (2009).
18. Aigbirhio FI, Alexakis E, Allen J. 15th International Isotope Society (UK group) Symposium. J. Labelled Compd. Radiopharm. 49(4), 377-420 (2006)